The price of added value for new anti-cancer drugs in France 2004-17

BARCELONA, Spain - Many new anti-cancer medicines add little value for patients compared to standard treatment and are rarely worth the extra cost, according to results of two studies investigating links between clinical benefit and pricing in Europe and the USA, reported at the ESMO Congress 2019. (1,2)

READ MORE

 

Clinical Benefit and Prices of Cancer Drugs in the US and Europe

BARCELONA, Spain - Many new anti-cancer medicines add little value for patients compared to standard treatment and are rarely worth the extra cost, according to results of two studies investigating links between clinical benefit and pricing in Europe and the USA, reported at the ESMO Congress 2019. (1,2)

READ MORE

 

Results of the ARTISTIC meta-analysis

The ARTISTIC collaboration meta-analysis included three randomised trials comparing adjuvant radiotherapy with early salvage radiotherapy following prostatectomy for men with localised prostate cancer: RADICALS (ISRCTN40814031), GETUG-AFU 17 (NCT00667069), and RAVES (NCT00860652). The analysis was planned before the results of the trials were known.

READ MORE (this report is linkd with the RADICALS-RT study; scroll down to see the abstract from th ARTISTIC study)

 

Men with Prostate Cancer can be Spared Radiotherapy after Surgery

BARCELONA, Spain – Men with prostate cancer can be spared radiotherapy after surgery, according to late breaking results of the RADICALS-RT trial presented at the ESMO Congress 2019 in Barcelona, Spain. (1) The study answers a longstanding question about whether the benefits of radiotherapy after surgery outweigh the side-effects.

READ MORE

 

Clinical Benefit with First-Line Immunotherapy in Advanced Hepatocellular Carcinoma

BARCELONA, Spain - New data have shown a trend towards clinically meaningful improvements in survival and response rates and a favorable safety profile with first-line immunotherapy compared to current standard treatment for advanced hepatocellular carcinoma (HCC). (1)

READ MORE